Evidence map›Paper›PMID 35655428›Full record

ArticleDrug testing and analysis2022

Sexually transmitted doping: The impact of urine contamination of semen.

David J Handelsman, Feyrous Bacha, Marsha DeBono, Sue Sleiman, Margaret R Janu

Open access · hybridAbstract read
In one paragraph

Article in Drug testing and analysis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

David J HandelsmanAndrology Department and Clinical Andrology Laboratory, Concord Hospital, Concord, NSW, Australia.ORCID https://orcid.org/0000-0002-4200-7476
Feyrous BachaAndrology Department and Clinical Andrology Laboratory, Concord Hospital, Concord, NSW, Australia.
Marsha DeBonoDiagnostic Pathology Unit, Concord Hospital, Concord, NSW, Australia.
Sue SleimanAndrology Department and Clinical Andrology Laboratory, Concord Hospital, Concord, NSW, Australia.
Margaret R JanuDiagnostic Pathology Unit, Concord Hospital, Concord, NSW, Australia.
Concord Hospital · USThe University of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The high sensitivity of antidoping detection tests creates the possibility of inadvertent doping due to an athlete's unknowing ingestion of contaminated environmental sources such as dietary supplements, food, or drinks. Recently, athletes denying use of a prohibited substance have claimed that the positive antidoping tests was due to exchange of bodily fluids with a nonathlete partner using a prohibited substance. Measurement of drugs in semen is largely limited to one or very few samples due to the inaccessibility of sufficiently frequent semen samples for detailed pharmacokinetics. An emerging issue in semen drug measurements is that semen samples may contain residual urine from ejaculation left in the urethra; however, the urine content in semen samples has not been studied. In the present study, we employed concurrent creatinine measurements in urine and seminal plasma to determine the urine content of semen samples.

Indexed as

Doping in SportsAthletesDietary SupplementsDrug ContaminationHumansMaleSemendopingsemenseminal plasmaurine

Identifiers

PMID35655428
PMCPMC9545268
OpenAlexW4281689614

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.